/Not for distribution to U.S. news wire services or for dissemination in the United States/
VANCOUVER, BC, Dec. 11, 2024 /CNW/ - Principal Technologies Inc. (the "Company" or "Principal") (TSXV: PTEC) (FSE: J07), is pleased to announce that, on December 11, 2024, it signed an arm's length non-binding letter of intent ("LOI") to acquire a controlling interest in the equity of Syndermix AG ("Syndermix"). Syndermix is a Swiss based medical research and applications developer with 100% interests in three significant medical technologies (the "Medical Assets"). A summary of Syndermix and the LOI is as follows:
Read more at newswire.ca